MedPath

Prospective Observational study for Lesion of neoatherosclerosis; the efficacy of Alirocumab for the neoatherosclerosis Reaction Investigated by Serial optical coherence tomography

Not Applicable
Recruiting
Conditions
neoatherosclerosis
Registration Number
JPRN-UMIN000029207
Lead Sponsor
Kobe University Graduate School of Medicine. Division of Cardiovascular Medicine, Department of Internal Medicine.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
31
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who have received treatment with PCSK 9 inhibitor in the past (2) Patients whose treatment was interrupted before follow-up catheterization during the observation period (3) Patients underwent LDL apheresis. (4) In the case that the researchers judges it as inappropriate as the object of this research.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Exploratory research for the findings of optical coherence tomography after nine months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath